Tracking Your Tears In Early Test For Alzheimer's And Parkinson's

Good news! Amazing stuff! Confirms one more time that Israel is a hotbed for innovation!

Cry it all out!

"... Early detection is crucial for both diseases, however, as treatments to slow the progression of both are more successful the sooner they are administered. ...

LacriScan diagnosis test uses tears, which are both easily accessible and intrinsically linked to the central nervous system.  

Because of these two factors, “we can identify a component in the tears that reflects processes in the brain, and in the early stages before the patient with Alzheimer’s or Parkinson’s develops clinical symptoms,” ...

The diagnostic process itself is based on the commonly used Schirmer Test that monitors tear production, which involves inserting a paper strip inside the lower eyelid to gather the fluid. 

Once collected, the tears undergo ... patented analysis, looking for biochemical markers ... of the two diseases. The two ailments ... “have a shared identity. ...
... was already working with the use of tears as a diagnosis tool during his research into a rare genetic disorder called NGLY1 deficiency, which has less than 100 cases worldwide, but five instances in the same family in northern Israel. And one of the symptoms of NGLY1 deficiency is alacrima, or abnormal tear production. ” ...
While similar tests for neurological diseases using tears have already been developed, ... that his method differs in two ways: a more sensitive test response and analysis that looks for multiple brain chemical markers of the two diseases. ..."

Tracking Your Tears In Early Test For Alzheimer's And Parkinson's An Israeli researcher has patented a way of using a patient’s tears to diagnose Alzheimer’s and Parkinson’s – the two most common neurodegenerative diseases in the world – in their pre-symptom stages.